These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19507677)

  • 21. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
    Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
    Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US.
    McCarville MB; Streck CJ; Dickson PV; Li CS; Nathwani AC; Davidoff AM
    Radiology; 2006 Jul; 240(1):73-81. PubMed ID: 16793972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of photoacoustically derived hemoglobin and oxygenation measurements with contrast-enhanced ultrasound estimated vascularity and immunohistochemical staining in a breast cancer model.
    Eisenbrey JR; Merton DA; Marshall A; Liu JB; Fox TB; Sridharan A; Forsberg F
    Ultrason Imaging; 2015 Jan; 37(1):42-52. PubMed ID: 24652195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
    Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
    Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations.
    Gee MS; Saunders HM; Lee JC; Sanzo JF; Jenkins WT; Evans SM; Trinchieri G; Sehgal CM; Feldman MD; Lee WM
    Cancer Res; 2001 Apr; 61(7):2974-82. PubMed ID: 11306476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.
    Wood AK; Bunte RM; Cohen JD; Tsai JH; Lee WM; Sehgal CM
    Ultrasound Med Biol; 2007 Dec; 33(12):1901-10. PubMed ID: 17720299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography.
    Krix M; Kiessling F; Vosseler S; Farhan N; Mueller MM; Bohlen P; Fusenig NE; Delorme S
    Cancer Res; 2003 Dec; 63(23):8264-70. PubMed ID: 14678984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis?
    Shah F; Balan P; Weinberg M; Reddy V; Neems R; Feinstein M; Dainauskas J; Meyer P; Goldin M; Feinstein SB
    Vasc Med; 2007 Nov; 12(4):291-7. PubMed ID: 18048465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow.
    Goertz DE; Yu JL; Kerbel RS; Burns PN; Foster FS
    Cancer Res; 2002 Nov; 62(22):6371-5. PubMed ID: 12438217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time excitation-enhanced ultrasound contrast imaging.
    Forsberg F; Shi WT; Knauer MK; Hall AL; Vecchio C; Bernardi R
    Ultrason Imaging; 2005 Apr; 27(2):65-74. PubMed ID: 16231836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of contrast-enhanced ultrasound administration setups on microbubble enhancement: a focus on pediatric applications.
    Kramer MR; Bhagat N; Back SJ; Poznick L; Forsberg F; Darge K; Eisenbrey JR
    Pediatr Radiol; 2018 Jan; 48(1):101-108. PubMed ID: 28894889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral enhancement of breast cancers on contrast-enhanced ultrasound: correlation with microvessel density and vascular endothelial growth factor expression.
    Liu H; Jiang Y; Dai Q; Zhu Q; Wang L; Lu J
    Ultrasound Med Biol; 2014 Feb; 40(2):293-9. PubMed ID: 24315392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does contrast-enhanced ultrasound reveal tumor angiogenesis in pancreatic ductal carcinoma? A prospective study.
    Nishida M; Koito K; Hirokawa N; Hori M; Satoh T; Hareyama M
    Ultrasound Med Biol; 2009 Feb; 35(2):175-85. PubMed ID: 18845377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
    Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
    Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of tumor angiogenesis in a mouse PC-3 prostate cancer model using dynamic contrast-enhanced sonography.
    Lee HJ; Hwang SI; Chung JH; Jeon JJ; Choi JH; Jung HS
    J Ultrasound Med; 2012 Aug; 31(8):1223-31. PubMed ID: 22837286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.